(Q48292444)
Statements
GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors (English)
Yoon Lee
Aikaterini Vassilakos
Ningping Feng
Viengthong Lam
Hongsheng Xie
Ming Wang
Hongnan Jin
Keyong Xiong
Chenyi Liu
Jim Wright